Stock Events

Stock Events

Fennec Pharmaceuticals (ADH) Q4 2025 Earnings

13NovConfirmed

Q4 2024

Q2 2025

Q3 2025

Q4 2025

-0.22

-0.15

-0.09

-0.02

Details

Expected EPS

-0.022069884

Actual EPS

-0.020144926

Surprise EPS

0

Surprise Percent

+8.72%

Description

Fennec Pharmaceuticals (ADH) has reported earnings of -0.020144926 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.